Five Common Barriers to Optimal Launch Trajectory (Part 2 of 2)

June 8, 2017

Fifty percent of new drug launches do not achieve peak sales, with half of them missing their targeted goals by 50% or more.1 How can you avoid your new drug’s launch from becoming part of this statistic? Read on. In...

read more

Five Common Barriers to Optimal Launch Trajectory (Part 1)

April 28, 2017

New Drug Launch, Day 1… The most anticipated and pivotal day for a pharmaceutical company. It takes an average of 14 years and $2.6 billion dollars to bring a new drug to market; and once it receives the cherished FDA...

read more

Five Best Practices for Maintaining Sunshine Act Compliance

April 5, 2017

How drug companies can avoid penalties, revenue loss, resource drain, reputation issues, and relationship challenges With the passing of the Physician Payments Sunshine Act, the importance of precise and timely expense report management by drug manufacturers ballooned, magnifying the challenges...

read more

Understanding the Healthcare Transaction Model – Part 2

January 24, 2017

PART II As a healthcare marketer, it is important to understand the health transaction model. We recently talked about how good information is necessary as well as access to medications for healthcare providers. In this healthcare transaction model, the last...

read more

Understanding the Healthcare Transaction Model – Part 1

December 12, 2016

All healthcare transactions begin with the consumer. By transaction, I mean the literal interpretation of the word – taking an action across a set of circumstances. As Healthcare Marketers, it is critical that we understand how these transactions take place...

read more
1 2

Providing business consulting to the pharmaceutical, life sciences and healthcare industries  Learn more